The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is responsible of variable clinical manifestations, ranging from no symptoms to severe pneumonia with acute respiratory distress syndrome, septic shock, and multi-organ failure resulting in death. To date no specific antiviral dr...
Main Authors: | Lucia Gozzo, Pierluigi Viale, Laura Longo, Daniela Cristina Vitale, Filippo Drago |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01307/full |
Similar Items
-
Thromboelastography for rapid diagnosis of heparin-like anticoagulant release during anaphylaxis-induced coagulopathy in systemic mastocytosis: a case report
by: Rajkumar Rajendram, et al.
Published: (2025-01-01) -
Not Just Anticoagulation—New and Old Applications of Heparin
by: Lixuan Zang, et al.
Published: (2022-10-01) -
Anticoagulant Therapy in Moderate to Severe COVID-19 Patients
by: Agus Fitriyanto Achmad, et al.
Published: (2022-01-01) -
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
by: Mandeep Singh Rahi, et al.
Published: (2023-06-01) -
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial
by: Michelle Sholzberg, et al.
Published: (2021-03-01)